Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Single-Nucleotide Polymorphism Genotyping Identifies a Locally Endemic Clone of Methicillin-Resistant Staphylococcus aureus

Abstract

We developed, tested, and applied a TaqMan real-time PCR assay for interrogation of three single-nucleotide polymorphisms that differentiate a clade (termed ‘t003-X’) within the radiation of methicillin-resistant Staphylococcus aureus (MRSA) ST225. The TaqMan assay achieved 98% typeability and results were fully concordant with DNA sequencing. By applying this assay to 305 ST225 isolates from an international collection, we demonstrate that clade t003-X is endemic in a single acute-care hospital in Germany at least since 2006, where it has caused a substantial proportion of infections. The strain was also detected in another hospital located 16 kilometers away. Strikingly, however, clade t003-X was not found in 62 other hospitals throughout Germany nor among isolates from other countries, and, hence, displayed a very restricted geographical distribution. Consequently, our results show that SNP-typing may be useful to identify and track MRSA clones that are specific to individual healthcare institutions. In contrast, the spatial dissemination pattern observed here had not been resolved by other typing procedures, including multilocus sequence typing (MLST), spa typing, DNA macrorestriction, and multilocus variable-number tandem repeat analysis (MLVA).

Introduction

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections [1], [2], [3]. It frequently causes outbreaks of infections that may spread within and between healthcare institutions [4]. Some strains of MRSA have demonstrably disseminated across hospitals around the globe within decades [5]. Especially at local and regional scales, however, the temporal and spatial dynamics of MRSA spread are poorly understood [6], [7]. It is usually not known, how commonly MRSA get transferred among healthcare institutions, how frequently novel strains get imported into a given medical facility, or what proportion of MRSA infections may be caused by strains that continuously circulate as endemic pathogens within a facility [8], [9]. Consequently, we currently lack important insight into the pace and range of MRSA dispersal, even though local epidemiology may have a profound impact on the cost and success of infection control measures [10], [11], [12], [13].

One reason for our limited knowledge about local-scale spread is that contemporary typing procedures identify genotypes that commonly display long-lasting persistence over entire countries or continents, and, as a consequence, provide little information about MRSA spread within a particular region [6], [7], [14], [15], [16]. For example, according to spa typing – a popular genotyping method based on sequence variation of a fragment from the staphylococcal spa gene [17] – 63% of MRSA from hospitals in all Germany currently display either one of only two types, which are dubbed t003 and t032, respectively [18]. Reportedly, the frequency of individual spa variants is even higher in some other regions [19]. Similarly, alternative typing methods for MRSA, including DNA macrorestriction (pulsed-field gel electrophoresis) and multilocus sequence typing (MLST), result in a small number of genotypes that dominate the pathogen population over large areas [6], [7], [20], [21], [22].

Recent technological advances have made DNA sequencing faster and more cost-effective by orders of magnitude [23]. Based on genome re-sequencing data from 63 MRSA isolates affiliated with a single MLST sequence type (ST239), including 20 isolates from one hospital, a recent study suggested that genome-wide single nucleotide polymorphisms (SNPs) could potentially be exploited to discriminate related isolates within a healthcare facility [5]. However, (re-)sequencing several millions of basepairs from each MRSA isolate for routine typing in epidemiological surveillance as yet is not economically feasible. Rather, it may be useful to ascertain polymorphic sites in the genomes from a limited number of isolates in a first step, and then to subsequently apply more cost-effective means to interrogate character states of the most informative SNPs [24], [25], [26].

In a previous study, we had ascertained genome-wide SNPs through mutation discovery within an international collection of MRSA ST225 isolates [16]. Here, we have applied TaqMan PCR to track an MRSA clone that could be identified on the basis of three of those SNPs.

Methods

Bacterial isolates

We investigated a total of 305 MRSA isolates displaying spa type t003. Ninety-nine of these isolates were collected from hospital X1 from 2006 through 2011, including 83 isolates from infections, nine isolates from carriers with no infections, and seven isolates with no information about clinical background. Another 16 t003 isolates were from hospital X2, including five from infections, six from asymptomatic carriage, and five without infection-related information.

Hospital X1 is a regional, general-care hospital with partial tertiary-care functions. It hosts 12 clinical departments and three interdisciplinary centers, two of which frequently exchange patients with other units. The hospital has a total of 500 beds and 50 day-care sites, and consists of a main facility and a side branch which is located 14 km apart. Hospital X2 is another general-care hospital in vicinity to hospital X1 (distance to X1, 16 km).

Further, we included 154 t003 isolates from 51 other hospitals throughout Germany. These isolates had been sent to the German national reference center for staphylococci for genotyping and further characterization. Finally, we included 36 t003 isolates from international sources, including the Czech Republic, Denmark, Switzerland, and the USA. The genomic diversity of these isolates had been investigated previously [16].

Upon request, we received 93 additional MRSA isolates that had been collected during the first half of 2010 from 11 hospitals located in the wider region around hospital X1 (distance to X1, 30 to 148 km). Only one of these isolates turned out to have the spa type t003; it was included among the above-described strain collection for SNP typing. The proportion of MRSA among S. aureus isolates from hospitals in this region is 20–25%, which is similar to German average [27].

Tree construction

We constructed a minimum spanning tree by using the Bionumerics software (Applied Maths, Ghent, Belgium). The maximum number of single-locus variants was prioritised and hypothetical nodes were allowed to decrease total tree length. Tree credibility was assessed by permutation resampling with 200 samples (see Bionumerics manual).

Spa typing, DNA macrorestriction, PCR

Spa typing and SmaI DNA macrorestriction (pulsed-field gel electrophoresis) of staphylococcal isolates was performed as described previously [14]. For PCR amplification and sequencing of loci au131, au133, and au345, previously published oligonucleotide primers were used [16].

Multilocus variable-number tandem repeat analysis (MLVA)

We investigated eight variable-number tandem repeat loci by PCR amplification and sequence analysis, applying previously described oligonucleotide primers [28]. Lengths of PCR products were determined by sequencing and used to deduce the numbers of repeats by comparison to a record of previously encountered allele sizes (provided by Leo Schouls, National Institute for Public Health and the Environment, Bilthoven, The Netherlands).

TaqMan PCR

Using Primer 3 software (available at http://frodo.wi.mit.edu/primer3) and Primer Express 3.0 software (Applied Biosystems, Foster City, CA, USA), we designed three TaqMan SNP allelic discrimination assays. For each of the three SNPs (Table 1), a pair of amplification primers was designed, and two differentially labelled TaqMan probes to hybridize with either one of the two alleles (Table 2). TaqMan probes (Applied Biosystems, Warrington, UK) were conjugated with 3′-minor-groove binder (3′-MGB) groups [29]. Real-time PCR was performed in 10-µl reactions containing 1 µM of each primer, 80 nM of each probe, 0.2 units of Platinum Taq polymerase (Invitrogen, Darmstadt, Germany), 1× Platinum Taq PCR buffer, 1.6 mM MgCl2, 0.2 mM of each dNTP (Invitrogen), and approximately 15 ng of template DNA. Thermal cycling was run on a Biorad CFX96 (Biorad, München, Germany) using the following conditions: 96°C for 5 minutes and 36 cycles of 96°C for 30 seconds, 58°C for 45 seconds, and 72°C for 1 minute.

The performance of the three TaqMan assays was tested on 73 isolates with known SNP genotypes. From 11 of these isolates (chosen randomly from our collection of t003 isolates from hospital X1), loci au131, au133, and au345 had been PCR-amplified and sequenced. Another 62 isolates had been screened for polymorphisms at these loci in a previous mutation discovery study [16].

Results

Choice of SNPs

From a panel of 47 SNPs that had been discovered in the course of a previously published study [16], we selected three mutations (Table 1) that define a monophyletic clade within the radiation of MRSA ST225, as illustrated in Figure 1. Character states at these bi-allelic SNPs define four different genotypes (i. e., allelic profiles, Figure 1). Notably, there were no homoplasies, as mutations at loci ST225_au345-1 and ST225_au131-1 in our present analysis were never found in the same isolate together, and they were not found in the absence of a mutation at locus ST225_au133-1. SNP ST225_au133-1 is most useful as it is phylogenetically informative and separates three genotypes (i. e., allelic profiles A-T-G, A-C-G, and A-T-T; Figure 1) from the root of the clade. These three genotypes appeared to have slightly different spatial and temporal distribution patterns. For example, only one of the genotypes was found on the neonatology and pediatrics wards (Figure S3). Further, there were extended time periods during which specific genotypes were not recovered from any infections (Figure S3). However, to avoid over-interpretation facing the small numbers of isolates assigned to each individual genotype, and for the sake of simplicity, we subsume these three genotypes under the term ‘clade t003-X’ in the following (Figure 1).

thumbnail
Figure 1. Minimum spanning tree illustrating the relationships between four SNP genotypes (corresponding to SNP allelic profiles T-T-G, A-T-G, A-C-G, A-T-T), defined through character states at three polymorphic positions in the MRSA genome (SNPs ST225_au133-1, ST225_au345-1, ST225_au131-1, respectively; see Table 1).

The tree is fully parsimonious (i. e., there is no alternative, equally optimal solution), as each of its branches yielded 100% permutation resampling support. Circle size is proportional to the number of isolates assigned to each of the genotypes. Grey shading indicates the proportion of isolates from administrative district X, collected from 2006 through 2011. Clade t003-X encompasses three SNP genotypes as indicated.

https://doi.org/10.1371/journal.pone.0032698.g001

Performance of TaqMan allelic discrimination assay

We used three dual-probe TaqMan 5′-nuclease PCR assays to interrogate three bi-allelic SNPs at distal positions on the MRSA genome. To facilitate single-base mismatch discrimination, TaqMan probes were equipped with 3′-MGB moieties [29]. All three assays exhibited efficient amplification of the corresponding SNP alleles (Figure S1). The minimum cycle thresholds (CT) varied from 12 to 19, depending on the assay and the template DNA, whereas the respective alternate alleles were not amplified (Figure S2). Of note, the observed variation of CT to some extent may have been caused by the varying quantity and quality of template DNA applied, since DNA samples initially had been extracted for the purpose of spa typing and most of them had been stored in the freezer for several years prior to being used in the present project.

When we tested these three TaqMan assays on 73 isolates with known SNP genotypes, SNPs were called correctly for all 73 isolates. Among 305 isolates tested in total, there were four isolates that repeatedly did not yield a fluorescence signal for locus ST225_au131-1, and sequence analysis revealed that one of these isolates had a point mutation (G>T) eight basepairs upstream from the SNP, resulting in a mismatch to the TaqMan probes. In addition, there was one isolate that repeatedly did not yield amplification products for two loci, ST225_au133-1 and ST225_au345-1. Locus au345 also failed to PCR-amplify when applying previously published primers [16], suggesting this locus may have been affected by a mutation (not shown). In summary, among 915 PCR assays performed, there were six assays (0.7%) in five isolates that failed repeatedly, and 300 isolates (98%) were fully typable at all three loci. The five non-typable isolates were removed from further analyses.

Abundance and distribution of clade t003-X

Among the 300 isolates fully genotyped, there were 72 isolates that displayed the derived character state at the phylogenetically informative SNP, i. e., allele A at SNP locus ST225_au133-1 (Figure 1). Among these 72 isolates, there were 14 isolates with allele C at SNP locus ST225_au345-1 (allelic profile, A-C-G) and six isolates with allele T at SNP locus ST225_au131-1 (A-T-T; Figure 1).

Remarkably, all 72 isolates in clade t003-X originated from only two hospitals (termed ‘X1’ and ‘X2’) within a single administrative district (termed ‘Landkreis X’, Figure 1). The majority (68 isolates, 94%) of t003-X isolates were found in hospital X1, where t003-X accounted for 9% to 33% of all MRSA that were sent for typing each year from 2006 through 2010 (Figure 2). In hospitals X1 and X2 together, t003-X accounted for 64% of t003 isolates and was detected on ten different wards total (Figure S3). In contrast, clade t003-X was not found among 154 ST225/t003 isolates from 51 other hospitals in Germany and among 36 additional isolates from Denmark, Switzerland, the Czech Republic and the USA (Figure 1). In a more targeted search, t003-X was also not found among 93 additional isolates from 11 hospitals located in the wider region around hospital X1 (not shown).

thumbnail
Figure 2. Proportion of clade t003-X, other spa type t003 isolates, and spa type t032 among MRSA from hospital X1.

Total numbers of MRSA isolates received from hospital X1 in individual years from 2006 through 2010 were 42, 38, 64, 60, and 74, respectively.

https://doi.org/10.1371/journal.pone.0032698.g002

DNA macrorestriction and MLVA did not identify clade t003-X

A subset of t003-X isolates, including isolates from each year from 2006 to 2009 and representing each of the three SNP genotypes in clade t003-X, were analysed by SmaI DNA macrorestriction (pulsed field gel electrophoresis). Banding patterns from these t003-X isolates were identical to those from several unrelated t003 isolates (Figure S4). Therefore, it was not possible to identify clade t003-X (or any of its subtypes) on the basis of DNA macrorestriction.

We genotyped a set of 26 isolates by applying a recently reported MLVA protocol (Table S1). Among all but two of the ST225 isolates, MLVA loci were almost fully conserved, and, as a consequence, MLVA was unable to identify clade t003-X (Table S1).

Discussion

By applying a TaqMan real-time PCR approach, we have determined character states at three previously ascertained bi-allelic SNPs in 305 MRSA isolates affiliated to spa type t003/MLST sequence type ST225. The TaqMan PCR performed efficiently, achieving 98% typeability (the proportion of isolates that could be genotyped), and results were fully concordant with dHPLC and Sanger sequencing. Costs for reagents (including the TaqMan probes) and disposables were moderate, amounting to 0.38 € per 10-µl reaction, or 1.14 € per isolate. This price, however, is based on the assumption that several thousand isolates are to be analysed totally, such that the costly TaqMan probes will get used up completely. Moreover, it does not include the cost of labor, rent, machines etc. Miniaturization and/or multiplexing could potentially improve costs, rapidity, and throughput of real-time PCR assays [30], [31].

As a result of typing isolates from an international collection, we have identified an MRSA clade (t003-X) that has caused a substantial proportion of infections in a single acute-care hospital (hospital X1), from at least 2006 through 2010 (Figure 2). In addition, four t003-X isolates were detected in another hospital (X2) that is located only 16 kilometers away from hospital X1, and it is possible that this MRSA has spread between the two institutions, for example, through patient transfers. Strikingly, however, t003-X was not found in any other hospital out of 62 that were investigated throughout Germany nor among ST225/t003 isolates from other countries. Consequently, t003-X displays a very restricted geographic distribution. It apparently has not disseminated far and its repeated introduction from outside the local area is unlikely. Rather, those point mutations that have enabled the clade's identification likely were acquired locally. In conclusion, the SNPs we have investigated enable the tracking of an MRSA clade that locally has been endemic for several years. In contrast, the spatial dissemination pattern of this MRSA had not been resolved on the basis of more convential typing procedures, including MLST, spa typing, DNA macrorestriction, and MLVA.

Our demonstration that a large proportion of MRSA isolates descend from a single clone calls for efforts to identify its reservoir(s), for example, through active surveillance cultures and SNP-based typing of the resulting MRSA isolates. Even though we found that t003-X was widespread among multiple wards within hospital X1 (Figure S3), it remains possible that the actual reservoir is outside the hospital, for example among repeatedly re-admitted patients or in a long-term care facility serving the hospital's catchment population. Such an external source for t003-X could be clarified through screening of patients upon admission to the hospital.

Spa typing indicated that multiple different strains of MRSA occurred in hospital X1 (Figure 2), several of which persisted from 2006 through 2010 (t004, t032, and t105; not shown). Notably, spa type t032 was particularly prevalent (Figure 2); it is affiliated to MLST sequence type ST22, which is the most frequently found MRSA strain in Germany and several other countries in Europe [18], [19]. Our results do not exclude that these ubiquitous spa types conceal other clones that may be locally endemic in hospital X1, in addition to t003-X. A comprehensive investigation into the complexity of the MRSA population structure in this hospital would require a SNP discovery study covering multiple clonal complexes.

Currently ongoing and future sequencing efforts will undoubtedly lead to the discovery of abundant polymorphisms in MRSA genomes. We predict that many of these polymorphisms will be useful to identify MRSA clones that are specific to geographic regions, to individual healthcare institutions, or even beyond, for example to departments, or wards, or patient cohorts within hospitals. If future research will confirm that local endemism of specific MRSA clones is a widespread phenomenon in many healthcare institutions, informative SNPs will likely be very helpful to identify the sources of nosocomial infections in individual patients. Once suitable polymorphisms have been ascertained, cost-effective means can be employed to probe character states for tracing routes of MRSA transmission.

Supporting Information

Figure S1.

Representative amplification curves.

https://doi.org/10.1371/journal.pone.0032698.s001

(PDF)

Figure S3.

Occurrence of clade t003-X and other t003 isolates on ten different wards in hospital X1 , 2006 through 2010.

https://doi.org/10.1371/journal.pone.0032698.s003

(PDF)

Figure S4.

SmaI DNA macrorestriction analysis of genomic DNA from t003 isolates, including five t003-X isolates as indicated. UPGMA clustering is based on the Dice similarity coefficient.

https://doi.org/10.1371/journal.pone.0032698.s004

(PDF)

Acknowledgments

We thank A. Weller, B. Pasemann, the technical staff of the national reference center for staphylococci in our laboratory, and the team at our DNA sequencing unit for excellent technical assistance. We are grateful to colleagues from multiple laboratories that provided their clinical MRSA isolates to the national reference center for staphylococci. We thank Leo Schouls for the MLVA allele size table.

Author Contributions

Conceived and designed the experiments: UN AN FL BS WW. Performed the experiments: UN. Analyzed the data: UN AN FL. Wrote the paper: UN FL BS WW.

References

  1. 1. Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis 13: 1840–1846.
  2. 2. de Kraker ME, Wolkewitz M, Davey PG, Grundmann H (2011) Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 55: 1598–1605.
  3. 3. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, et al. (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15: 19688.
  4. 4. Dennesen PJ, Bonten MJ, Weinstein RA (1998) Multiresistant bacteria as a hospital epidemic problem. Ann Med 30: 176–185.
  5. 5. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, et al. (2010) Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469–474.
  6. 6. Willems RJ, Hanage WP, Bessen DE, Feil EJ (2011) Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev.
  7. 7. Nübel U, Strommenger B, Layer F, Witte W (2011) From types to trees: Reconstructing the spatial spread of Staphylococcus aureus based on DNA variation. Int J Med Microbiol 301: 614–618.
  8. 8. Dulon M, Haamann F, Peters C, Schablon A, Nienhaus A (2011) MRSA prevalence in European healthcare settings: a review. BMC Infect Dis 11: 138.
  9. 9. Thompson RL, Cabezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 309–317.
  10. 10. Marshall C, Wesselingh S, McDonald M, Spelman D (2004) Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect 56: 253–268.
  11. 11. Rubinovitch B, Pittet D (2001) Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 47: 9–18.
  12. 12. Lucet JC, Regnier B (2010) Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? Clin Infect Dis 51: 585–590.
  13. 13. Cookson B, Bonten MJ, Mackenzie FM, Skov RL, Verbrugh HA, et al. (2011) Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents 37: 195–201.
  14. 14. Strommenger B, Braulke C, Heuck D, Schmidt C, Pasemann B, et al. (2008) Spa-typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol 46: 574–581.
  15. 15. Nübel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, et al. (2008) Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 105: 14130–14135.
  16. 16. Nübel U, Dordel J, Kurt K, Strommenger B, Westh H, et al. (2010) A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathogens 6: e1000855.
  17. 17. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, et al. (2004) spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 42: 792–799.
  18. 18. Witte W, Klare I, Nübel U, Strommenger B, Werner G (2008) Emergence and spread of antibiotic resistant Gram positive bacterial pathogens. International Journal of Medical Microbiology 298: 365–377.
  19. 19. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, et al. (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7: e1000215.
  20. 20. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, et al. (2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41: 5113–5120.
  21. 21. Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, et al. (2003) Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 41: 1574–1585.
  22. 22. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, et al. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99: 7687–7692.
  23. 23. Metzker ML (2010) Sequencing technologies - the next generation. Nat Rev Genet 11: 31–46.
  24. 24. Holt KE, Baker S, Dongol S, Basnyat B, Adhikari N, et al. (2010) High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 10: 144.
  25. 25. Okinaka RT, Henrie M, Hill KK, Lowery KS, Van Ert M, et al. (2008) Single nucleotide polymorphism typing of Bacillus anthracis from Sverdlovsk tissue. Emerg Infect Dis 14: 653–656.
  26. 26. Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, et al. (2010) Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 42: 1140–1143.
  27. 27. Anonymous (2010) Antimicrobial resistance surveillance in Europe – annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009. Stockholm, Sweden: European Centre for Disease Prevention and Control.
  28. 28. Schouls LM, Spalburg EC, van Luit M, Huijsdens XW, Pluister GN, et al. (2009) Multiple-locus variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-typing. PLoS One 4: e5082.
  29. 29. Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, et al. (2000) 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 28: 655–661.
  30. 30. Neuzil P, Zhang C, Pipper J, Oh S, Zhuo L (2006) Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes. Nucleic Acids Res 34: e77.
  31. 31. Gunson RN, Bennett S, Maclean A, Carman WF (2008) Using multiplex real time PCR in order to streamline a routine diagnostic service. J Clin Virol 43: 372–375.